Such models have found applications in CD4+ T cell responses to influenza infections, multiscale mechanistic modeling of human dendritic cells, and have potential applications in dendritic cell-based targeted cell therapies (Wertheim et al., 2021; Aghamiri et al., 2023). Here, CD4 is linked to influenza.